Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
6 NC counties are under alert.
Just In
NC lawmakers approve almost $68 million in child care subsidies, amid concerns that centers would close
Program
On WRAL at 6: Are insurance companies watching your home? WRAL's Keely Arthur dives into reports of drones being used to adjust your rates!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics Inc
(NQ:
STOK
)
13.31
+0.39 (+3.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,339,777
Open
12.97
Bid (Size)
12.69 (1)
Ask (Size)
14.45 (2)
Prev. Close
12.92
Today's Range
12.76 - 13.38
52wk Range
3.350 - 17.58
Shares Outstanding
44,188,534
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
June 24, 2024
Via
Benzinga
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 18, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Performance
YTD
+127.13%
+127.13%
1 Month
-5.37%
-5.37%
3 Month
-1.41%
-1.41%
6 Month
+146.48%
+146.48%
1 Year
+21.11%
+21.11%
More News
Read More
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
June 03, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 17, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Analyst Expectations For Stoke Therapeutics's Future
May 06, 2024
Via
Benzinga
Assessing Stoke Therapeutics: Insights From 6 Financial Analysts
April 04, 2024
Via
Benzinga
STOK Stock Earnings: Stoke Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 06, 2024
Via
InvestorPlace
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 06, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
April 29, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
April 17, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
March 27, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
What's Going On With Stoke Therapeutics Stock Tuesday?
March 26, 2024
Via
Benzinga
Stoke Therapeutics Announces Proposed Public Offering
March 26, 2024
From
Stoke Therapeutics, Inc.
Via
Business Wire
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates
March 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
Dow Gains 100 Points; McCormick Posts Upbeat Results
March 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stoke Therapeutics Inc. (NASDAQ: STOK) Near the Top of Equities by Percentage Gain on 3/26
March 26, 2024
Via
Investor Brand Network
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
March 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients
March 26, 2024
Via
Benzinga
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
March 26, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.